Diverse Effect of Inflammatory Markers on Insulin Resistance and Insulin‐Resistance Syndrome in the Elderly

Journal of the American Geriatrics Society - Tập 52 Số 3 - Trang 399-404 - 2004
Angela Marie Abbatecola1, Luigi Ferrucci1, Rodolfo Grella1, Stefania Bandinelli1, Massimiliano Bonafè1, Michelangela Barbieri1, J. Gerl1, Fulvio Lauretani1, Claudio Franceschi1, Giuseppe Paolisso1
1From the *Department of Geriatric Medicine and Metabolic Diseases, II University of Naples, Naples, Italy†Laboratory of Clinical Epidemiology, INRCA Geriatric Department, Florence, Italy‡Department of Experimental Pathology, University of Bologna, Bologna, Italy

Tóm tắt

Objectives: To evaluate the potential association between different inflammatory markers and insulin resistance (IR), as well as insulin‐resistance syndrome (IRS) in a large, population‐based study of older, nondiabetic persons.Design: Cross‐sectional study.Setting: Outpatient clinic in Greve in Chianti and Bagno a Ripoli (Italy).Participants: One thousand one hundred forty‐six nondiabetic subjects ranging in age from 22 to 104.Measurements: Anthropometric measurements; plasma fasting levels of glucose, insulin, and cholesterol (total, high‐density lipoprotein, low‐density lipoprotein); homeostasis model assessment to estimate degree of insulin resistance; tumor necrosis factor α (TNF‐α), interleukin 6 (IL‐6), soluble IL‐6 receptor (sIL‐6R), interleukin receptor antagonist (IL‐1ra), and C‐reactive protein (CRP) plasma concentrations; diastolic, systolic, and mean arterial blood pressure; and echo‐color‐Doppler duplex scanning examination of carotid arteries.Results: Insulin resistance correlated with age (r=0.102; P<.001) and plasma levels of TNF‐α (r=0.082; P=.007), IL‐1ra (r=0.147; P<.001), IL‐6 (r=0.133; P<.001), sIL‐6R (r=−0.156; P<.001), and CRP (r=0.83; P<.001). Subjects in the upper tertile of IR degree were older and had higher serum levels of TNF‐α, IL‐1ra, and IL‐6 and lower levels of sIL‐6R than subjects in the lowest tertile. Independent of age, sex, body mass index, waist‐to‐hip ratio, triglycerides, drug intake, diastolic blood pressure, smoking habit, and carotid atherosclerotic plaques, higher IL‐6 (t=2.987; P=.003) serum concentrations were associated with higher IR, whereas sIL‐6R levels (t=−5.651; P<.001) were associated with lower IR. Furthermore, IL‐1ra concentrations (t=2.448; P=.015) were associated with IRS, and higher sIL‐6R plasma levels continued to correlate negatively with IRS.Conclusion: Different inflammatory markers are associated with a diverse effect on IR and IRS in elderly nondiabetic subjects.

Từ khóa


Tài liệu tham khảo

10.1097/00062752-200105000-00001

10.1111/j.1749-6632.2000.tb06651.x

10.1111/j.1532-5415.1993.tb02054.x

10.1002/eji.1830230950

Albright JW, 2000, Soluble receptors and other substances that regulate proinflammatory cytokines in young and aging humans, J Gerontol A Biol Sci Med Sci, 55, 20, 10.1093/gerona/55.1.B20

10.1046/j.1365-2249.2000.01281.x

Paolisso G, 1998, Advancing age and insulin resistance, Role of plasma tumor necrosis factor-α, 275, 294

Hak AE, 2001, Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly, The Rotterdam study, 86, 4398

10.1096/fj.99-1003rev

Pickup JC, 1997, NIDDM as a disease of the innate immune system, Association of acute-phase reactants and interleukin-6 with metabolic syndrome X, 40, 1286

10.2337/diacare.14.3.173

10.1111/j.1532-5415.2000.tb03873.x

Alberti KG, 1998, Definition, diagnosis, and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation, 15, 539

10.2337/diacare.23.1.57

Friedewald WT, 1972, Estimation of serum low‐density lipoprotein without the use of a preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

10.1007/s00125-002-0829-2

Dandona P, 2002, The anti‐inflammatory and potential anti‐atherogenic effect of insulin, A new paradigm, 45, 924

10.1210/jcem.86.3.7305

10.1210/jc.82.12.4196

10.1210/jcem.87.5.8450

10.1097/00003677-200204000-00008

10.1152/ajpendo.2001.280.5.E745

10.1074/jbc.275.21.15985

10.1084/jem.193.2.263

Krebs DL, 2000, SOCS. Physiological suppressors of cytokine signaling, J Cell Sci, 13, 2813, 10.1242/jcs.113.16.2813

Muller‐Newman G, 1998, Soluble IL‐6 receptor potentates the antagonistic activity of soluble gp130 on IL‐6 responses, J Immunol, 161, 6347, 10.4049/jimmunol.161.11.6347

Meier C, 2002, IL‐1 receptor antagonist serum levels are increased in human obesity, A possible link to the resistance to leptin?, 87, 1184

10.1046/j.1365-2796.2002.00926.x

10.2337/diacare.24.2.245